Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2020-02-14 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Share Issue/Capital Change Classification · 99% confidence The document is very short (1490 characters) and contains an RNS Number, indicating it is a regulatory announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' for an auction call period, which is a procedural market announcement rather than a substantive financial report (like 10-K, ER, or IR). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or DLST, the most appropriate fallback category is Regulatory Filings (RNS).
2020-02-14 English
Half Year Report
Earnings Release Classification · 100% confidence The document explicitly states it is the "Half Year Report" for the six months ended 30 November 2019. This content, which includes detailed Corporate & Operational Highlights and Financial Highlights (Revenue, Expenses, Loss after tax, Cash balance), is characteristic of a comprehensive financial report covering a period shorter than a full year. This aligns directly with the definition of an Interim / Quarterly Report (Code: IR). Although it is distributed via RNS (RNS Number : 6900C), the core content is the report itself, not just an announcement of its publication. H1 2020
2020-02-12 English
Lung Test More Cost Effective Compared to CT
Environmental & Social Information Classification · 99% confidence The document begins with an 'RNS Number' and is dated January 28, 2020. It announces positive findings from a study regarding the company's EarlyCDT Lung Test, referencing external sources like NIHR Leeds MIC and providing contact information for brokers and media. The structure, use of RNS numbering, and the nature of the announcement (a positive development/update) strongly indicate a regulatory news service release. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2020-01-28 English
Notice of Capital Markets Update
Report Publication Announcement Classification · 99% confidence The document is identified by the RNS Number header and explicitly states it is a 'Notice of Capital Markets Update' regarding upcoming half-year results. It is a short announcement detailing an event (Capital Markets Update) rather than the full financial report itself (which would be an IR or 10-K). Since it is a formal regulatory announcement distributed via RNS (London Stock Exchange's news service), and it announces an event/update rather than being a core financial statement, it fits best under the general Regulatory Filings category (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing the release of the results document. However, since the primary focus is announcing the *event* (Capital Markets Update) where results will be discussed, and it is distributed via RNS, RNS is the most appropriate general classification for this type of market notice that doesn't fit a more specific category like DIV or DIRS. Given the content is a formal notice distributed via the RNS system, RNS is the most fitting general regulatory announcement code.
2020-01-27 English
Consortium of Liver Cancer Industry Leaders
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content describes the company's participation in a research consortium for early cancer detection. This is a general corporate update that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Since it is a standard, non-specific regulatory news item distributed through RNS, the most appropriate classification is the general regulatory filing category.
2020-01-23 English
Notice of Half Year Results
Report Publication Announcement Classification · 99% confidence The document is very short (3703 characters) and its primary purpose is to announce that the company will be releasing its 'half year results' on a future date (February 12, 2020). It explicitly states 'Notice of Half Year Results'. This structure—announcing the timing of a future report rather than containing the full report itself—fits the definition of a Report Publication Announcement (RPA). Although it relates to an Interim/Quarterly Report (IR), the document itself is the announcement of that report's publication, triggering the 'MENU VS MEAL' rule.
2020-01-07 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.